Association Between Buprenorphine/Naloxone Sublingual Tablet And All‐Cause Mortality In Patients Receiving Medication Assisted Treatment For Opioid Addiction In UK

Aug-16

AUTHORS : Jinghua He, Merck Sharp & Dohme, Kenilworth, New Jersey, USA – Email: Jinghua_he@merck.com OR Dr Sabine M. Apelt, Certum Consulting, Bergkirchen, Germany – Email: info@certum-consulting.com – Profile: https://certum-consulting.com/contact-person/

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 25(S3):581

DOI : 10.1002/pds.4070

Association Between Buprenorphine/Naloxone Sublingual Tablet And All‐Cause Mortality In Patients Receiving Medication Assisted Treatment For Opioid Addiction In UK

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study